Captor Therapeutics Spolka Akcyjna (WSE:CTX)
74.80
-0.30 (-0.40%)
Jul 3, 2026, 5:00 PM CET
WSE:CTX Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, WSE:CTX stock has a consensus rating of "Strong Buy" and an average price target of zł 86.83. The average 1-year stock price forecast is 16.08% higher than the current stock price, while the lowest is zł 67.00 (-10.43%) and the highest is zł 110.00 (+47.06%).
Price Target: zł 86.83 (+16.08%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for WSE:CTX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
56.70M
from 4.66M
Increased by 1,116.74%
Revenue Next Year
48.50M
from 56.70M
Decreased by -14.46%
EPS This Year
-0.52
from -7.61
EPS Next Year
-0.26
from -0.52
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 80.0M | ||
| Avg | 56.7M | ||
| Low | 33.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,616.7% | ||
| Avg | 1,116.7% | ||
| Low | 616.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.07 | ||
| Avg | -0.52 | ||
| Low | -4.10 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |